November 3 (SeeNews) - Bulgarian drug maker Sopharma [BUL:SFA] said its standalone net profit increased to 25.4 million levs ($12.68 million/12.99 million euro) in the first nine months of 2022 from 22.4 million levs in the same period of 2021.